Glycine is a natural amino acid neurotransmitter that acts as a co-agonist at NMDA receptors
in brain. We hypothesize that symptoms of the schizophrenia prodrome will improve with
glycine to a greater degree than with placebo.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Yale University
Collaborators:
Glytech, Inc National Alliance for Research on Schizophrenia and Depression